{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Promotion of unproven and potentially unsafe treatments for COVID-19\",\"Impact\":\"Risk of harm to individuals, false sense of security, delays in seeking appropriate treatment\",\"Mitigation\":\"Promote evidence-based treatments, educate the public on the risks of unproven treatments, regulate promotion of pharmaceuticals\",\"Technologies\":\"Regulatory frameworks, public health campaigns, evidence-based medicine guidelines\",\"People\":\"General public, patients, healthcare providers\",\"Owner\":\"Regulatory bodies, healthcare organizations, public health authorities\"},{\"Description\":\"Misinformation and confusion about the efficacy of drugs for COVID-19 treatment\",\"Impact\":\"Uncertainty about effective treatments, potential misuse of medications, distrust in healthcare recommendations\",\"Mitigation\":\"Provide clear and accurate information on drug efficacy, monitor and correct misinformation, promote transparency in clinical trials and research\",\"Technologies\":\"Information dissemination platforms, fact-checking tools, data monitoring and analysis systems\",\"People\":\"General public, healthcare providers, researchers\",\"Owner\":\"Health organizations, government agencies, research institutions\"},{\"Description\":\"Delayed development and evaluation of safe and effective treatments\",\"Impact\":\"Lack of timely access to effective therapies, prolonged impact of the pandemic, increased burden on healthcare systems\",\"Mitigation\":\"Invest in research and development, streamline regulatory processes, promote collaboration and data sharing among researchers\",\"Technologies\":\"Clinical research platforms, data sharing infrastructure, research funding mechanisms\",\"People\":\"Patients, healthcare providers, researchers\",\"Owner\":\"Pharmaceutical companies, research institutions, government funding agencies\"}]}"}}